Maternal Obesity Linked to Impaired Fetal Iron Transfer

Share this article:
Maternal Obesity Linked to Impaired Fetal Iron Transfer
Maternal Obesity Linked to Impaired Fetal Iron Transfer

(HealthDay News) – Maternal obesity is associated with impaired iron transfer to the fetus, possibly through upregulation of hepcidin.

Maria C Dao, from the Jean Mayer USDA Human Nutrition Research Center on Aging in Boston, and colleagues examined the effect of obesity-related inflammation on maternal and fetal iron status in 15 obese and 15 lean control women recruited in their second trimester of pregnancy. Maternal and cord blood was used to measure markers of iron status, inflammation, and hepcidin.

The researchers found that maternal C-reactive protein and hepcidin were significantly higher in the obese group compared to the controls, while cord blood iron was significantly lower in the obese group compared with lean controls. There was a significant negative correlation between maternal body mass index and hepcidin with cord blood iron status.

"In conclusion, we have shown, for the first time, that maternal obesity is associated with impaired iron transfer to the fetus," the authors write. "We speculate that this is due to the effects of a chronic proinflammatory environment and increased levels of hepcidin."

Abstract
Full Text (subscription or payment may be required)

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs